Follistatin‐like 1 promotes cardiac fibroblast activation and protects the heart from rupture

Follistatin‐like 1 (Fstl1) is a secreted protein that is acutely induced in heart following myocardial infarction (MI). In this study, we investigated cell type‐specific regulation of Fstl1 and its function in a murine model of MI. Fstl1 was robustly expressed in fibroblasts and myofibroblasts in the infarcted area compared to cardiac myocytes. The conditional ablation of Fstl1 in S100a4‐expressing fibroblast lineage cells (Fstl1‐cfKO mice) led to a reduction in injury‐induced Fstl1 expression and increased mortality due to cardiac rupture during the acute phase. Cardiac rupture was associated with a diminished number of myofibroblasts and decreased expression of extracellular matrix proteins. The infarcts of Fstl1‐cfKO mice displayed weaker birefringence, indicative of thin and loosely packed collagen. Mechanistically, the migratory and proliferative capabilities of cardiac fibroblasts were attenuated by endogenous Fstl1 ablation. The activation of cardiac fibroblasts by Fstl1 was mediated by ERK1/2 but not Smad2/3 signaling. This study reveals that Fstl1 is essential for the acute repair of the infarcted myocardium and that stimulation of early fibroblast activation is a novel function of Fstl1.

[1]  K. Nose,et al.  Cloning from a mouse osteoblastic cell line of a set of transforming-growth-factor-beta 1-regulated genes, one of which seems to encode a follistatin-related polypeptide. , 1993, European journal of biochemistry.

[2]  D. Brenner,et al.  Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. , 2014, The Journal of clinical investigation.

[3]  M. Daemen,et al.  Mouse strain determines the outcome of wound healing after myocardial infarction. , 2009, Cardiovascular research.

[4]  K. Walsh Adipokines, myokines and cardiovascular disease. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[5]  J. Kellum,et al.  Follistatin‐like protein 1 enhances NLRP3 inflammasome‐mediated IL‐1β secretion from monocytes and macrophages , 2014, European journal of immunology.

[6]  N. Frangogiannis,et al.  Fibroblasts in myocardial infarction: a role in inflammation and repair. , 2014, Journal of molecular and cellular cardiology.

[7]  T. Murohara,et al.  Therapeutic Impact of Follistatin-Like 1 on Myocardial Ischemic Injury in Preclinical Models , 2012, Circulation.

[8]  M. Sixt Cell migration: Fibroblasts find a new way to get ahead , 2012, The Journal of cell biology.

[9]  F. Lateef,et al.  Ventricular free wall Rupture after Myocardial Infarction , 2003 .

[10]  Jing Han,et al.  TSC-36/FRP inhibits vascular smooth muscle cell proliferation and migration. , 2006, Experimental and molecular pathology.

[11]  K. Walsh,et al.  Follistatin-Like 1 Is an Akt-Regulated Cardioprotective Factor That Is Secreted by the Heart , 2008, Circulation.

[12]  K. Walsh,et al.  DIP2A Functions as a FSTL1 Receptor* , 2010, The Journal of Biological Chemistry.

[13]  A. Ishisaki,et al.  Fibroblast growth factor-1-induced ERK1/2 signaling reciprocally regulates proliferation and smooth muscle cell differentiation of ligament-derived endothelial progenitor cell-like cells. , 2011, International journal of molecular medicine.

[14]  P. Pappas,et al.  Ventricular free-wall rupture after myocardial infarction. Treatment and outcome. , 1991, Chest.

[15]  R. Lidón,et al.  Changes in Hospital Mortality Rates in 425 Patients With Acute ST-Elevation Myocardial Infarction and Cardiac Rupture Over a 30-Year Period , 2008, Circulation.

[16]  Jane A. Linderbaum,et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[17]  P. Carmeliet,et al.  Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction , 2009, The Journal of experimental medicine.

[18]  Nguyen T. Nguyen,et al.  SPARC mediates early extracellular matrix remodeling following myocardial infarction. , 2011, American journal of physiology. Heart and circulatory physiology.

[19]  K. Walsh,et al.  Follistatin-Like 1 in Chronic Systolic Heart Failure: A Marker of Left Ventricular Remodeling , 2011, Circulation. Heart failure.

[20]  Y. Geng,et al.  Blocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in mice , 2015, The Journal of experimental medicine.

[21]  M. V. D. van den Hoff,et al.  Follistatin-like 1 in vertebrate development. , 2013, Birth defects research. Part C, Embryo today : reviews.

[22]  F. Strutz,et al.  Identification and characterization of a fibroblast marker: FSP1 , 1995, The Journal of cell biology.

[23]  N. Rosenthal,et al.  Expression of follistatin-related genes is altered in heart failure. , 2008, Endocrinology.

[24]  Aubie K. Shaw,et al.  TGFβ Signaling in Myeloid Cells Regulates Mammary Carcinoma Cell Invasion through Fibroblast Interactions , 2015, PloS one.

[25]  A. McMahon,et al.  Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. , 2010, The American journal of pathology.

[26]  M. Gouda,et al.  Is it ever possible to treat left ventricular free wall rupture conservatively? , 2014, Interactive cardiovascular and thoracic surgery.

[27]  Bin Zhou,et al.  Epicardial FSTL1 reconstitution regenerates the adult mammalian heart , 2015, Nature.

[28]  S. Butz,et al.  GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice , 2011, Nature Medicine.

[29]  H. Katus,et al.  Identification of follistatin-like 1 by expression cloning as an activator of the growth differentiation factor 15 gene and a prognostic biomarker in acute coronary syndrome. , 2012, Clinical chemistry.

[30]  K. Walsh,et al.  Cardiokines: recent progress in elucidating the cardiac secretome. , 2012, Circulation.

[31]  N. Frangogiannis,et al.  Fibroblasts in post-infarction inflammation and cardiac repair. , 2013, Biochimica et biophysica acta.

[32]  A. Schwab,et al.  PDGFR&agr; signaling in the primary cilium regulates NHE1-dependent fibroblast migration via coordinated differential activity of MEK1/2–ERK1/2–p90RSK and AKT signaling pathways , 2012, Journal of Cell Science.

[33]  J. Hochman,et al.  Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? , 2000, Journal of the American College of Cardiology.

[34]  T. Murohara,et al.  Muscle-derived follistatin-like 1 functions to reduce neointimal formation after vascular injury. , 2014, Cardiovascular research.

[35]  Elena Aikawa,et al.  Matrix Metalloproteinase-13/Collagenase-3 Deletion Promotes Collagen Accumulation and Organization in Mouse Atherosclerotic Plaques , 2005, Circulation.

[36]  H. Katus,et al.  Circulating concentrations of follistatin-like 1 in healthy individuals and patients with acute coronary syndrome as assessed by an immunoluminometric sandwich assay. , 2009, Clinical chemistry.

[37]  Maria Carla Ferrari,et al.  Ras Activated ERK and PI3K Pathways Differentially Affect Directional Movement of Cultured Fibroblasts , 2013, Cellular Physiology and Biochemistry.

[38]  C. Smas,et al.  Downregulated expression of the secreted glycoprotein follistatin-like 1 (Fstl1) is a robust hallmark of preadipocyte to adipocyte conversion , 2010, Mechanisms of Development.

[39]  M. Grigorian,et al.  S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes. , 2007, Cardiovascular research.

[40]  B. Gersh,et al.  Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction , 2011 .

[41]  B. Joung,et al.  Heart Failure : A Cardio-renal-vascular Syndrome(Special Lecture 13,The 73rd Annual Scientific Meeting of The Japanese Circulation Society) , 2009 .

[42]  K. Walsh,et al.  Follistatin-like 1, a Secreted Muscle Protein, Promotes Endothelial Cell Function and Revascularization in Ischemic Tissue through a Nitric-oxide Synthase-dependent Mechanism* , 2008, Journal of Biological Chemistry.

[43]  R. Kalluri,et al.  Origins of cardiac fibroblasts. , 2010, Circulation research.

[44]  Kazuto Nakamura,et al.  Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload , 2011, Proceedings of the National Academy of Sciences.

[45]  K. Nose,et al.  Structural Characterization of TSC-36/Flik , 2004, Journal of Biological Chemistry.

[46]  J. Eckel,et al.  Regulation of follistatin-like protein 1 expression and secretion in primary human skeletal muscle cells , 2013, Archives of physiology and biochemistry.

[47]  R. M. Rubison,et al.  A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. , 1996, Journal of the American College of Cardiology.

[48]  E. Birgitte Lane,et al.  ‘See-saw’ expression of microRNA-198 and FSTL1 from a single transcript in wound healing , 2013, Nature.

[49]  宮前 多佳子 Follistatin-like protein-1 is a novel proinflammatory molecule , 2007 .

[50]  R. Gomer,et al.  Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice , 2006, Proceedings of the National Academy of Sciences.

[51]  Dong I. Lee,et al.  Cardiomyocyte-Specific Transforming Growth Factor &bgr; Suppression Blocks Neutrophil Infiltration, Augments Multiple Cytoprotective Cascades, and Reduces Early Mortality After Myocardial Infarction , 2014, Circulation research.

[52]  V. Fuster,et al.  Epithelial-to-Mesenchymal and Endothelial-to-Mesenchymal Transition: From Cardiovascular Development to Disease , 2012, Circulation.

[53]  Y. Geng,et al.  Impaired Elastin Deposition in Fstl1−/− Lung Allograft under the Renal Capsule , 2013, PloS one.

[54]  Merry L Lindsey,et al.  Altered fibroblast function following myocardial infarction. , 2005, Journal of molecular and cellular cardiology.

[55]  H. Blair,et al.  Follistatin-like protein 1 is a mesenchyme-derived inflammatory protein and may represent a biomarker for systemic-onset juvenile rheumatoid arthritis. , 2010, Arthritis and rheumatism.

[56]  J. H. Koolstra,et al.  The BMP Antagonist Follistatin-Like 1 Is Required for Skeletal and Lung Organogenesis , 2011, PloS one.